AWARDDEFINITIVE CONTRACTSmall business
Definitive contract 75N93022C00004PAI LIFE SCIENCES INC
Overview
Award facts
- Net obligations
- $597.95K
- $597,953of $597.95K potential value
- Outlays (paid to date)
- $597.95K
- $597.95K paid of $597.95K obligated$597,953
- Period of performance
- Jan 10, 2022 to Jan 9, 2024
- Ended
- Modifications
- 3
- Latest action Sep 14, 2022
- Contract type
- Definitive contract
- PIID 75N93022C00004
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
LATE STAGE ADJUVANT MIMICS BASED ON TLR4 AGONISTS
Dates and value
- Award date
- Signed on Jan 7, 2022
- Potential end of performance
- Jan 8, 2024
- Current value
- $597,953Base and exercised options
- Potential value (if all options are exercised)
- $597,953
Obligations by fiscal year of action
- FY2022: $597,953
Total across 1 fiscal year: $597,953
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Sep 14, 2022. View on USAspending · Recipient on SAM.gov
Recipient
LocationSEATTLE, WA
UEIMSMLUCM9DRT6
CAGE code47SX4
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyPAI LIFE SCIENCES INC
Business types and certifications
For-profit organizationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded from
- National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Seattle, King County, Washington 98102-3739
- Congressional district (place of performance)
- WA-07As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH (research and development)
Competition
- Extent competed
- Full and open competition after exclusion of sourcesD
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- Small business set aside - totalSBA
- Contract pricing
- Firm fixed priceJ
- Offers received
- 3
Solicitation and notices
- Solicitation ID
- PHS2021-01(as reported)
- Solicitation date
- Jul 28, 2020
Contract details
- Subcontracting plan
- Plan not requiredB
- Major program
- Late stage adjuvant mimics based on tlr4 agonists.
- Cost Accounting Standards clause
- No - CAS waiver approvedN
- Certified cost or pricing data
- No
- Service Contract Act labor standards
- No
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Jan 7, 2022Base obligation at award: $597,953
- Latest action
- Sep 14, 2022 — Other administrative actionModification P00003; administrative: no change in scope or value
- Actions by type
- Base award1
- Other administrative action3
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
- Walsh-Healey Act (materials and supplies)
- No
- Construction wage rates (Davis-Bacon)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N930
- Transactions recorded under this award key
- 4
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N930
- Treasury accounts
- 075-2022/2022-0885-000
- Object classes
- 25.5: Research and development contracts
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression